$NMTC

NeuroOne Medical Technologies Corp (NMTC) reported a significant increase in product revenue of 163% to $9.1 million for fiscal year 2025, alongside improved gross margins and reduced operating expenses. The company also secured FDA 510(k) clearance for its OneRF trigeminal nerve ablation system and strengthened its balance sheet with an $8.2 million capital raise. Despite these successes, NMTC faces challenges such as NASDAQ compliance, obtaining ISO 13485 certification, and establishing strategic partnerships for its new platforms.